SIR a Clandestine Way to Implement NRC: Kerala Legislative Assembly

THE Kerala Legislative Assembly unanimously demanded that the Election Commission should desist from actions that violate Fundamental Rights and proceed with a transparent updating of the electoral rolls.

Indian Companies Complicit in Israel’s Genocide of Palestinians

THE Israeli genocide of Palestinians has been going on for two years – a ‘live-streamed genocide’, as Amnesty International called it in April 2025 in its annual report. Thus far, Israel has murdered over 66,000 Palestinians – the overwhelming majority being civilians, and 20,000 of the dead being children (a Palestinian child has been killed every hour since October 2023).

GST Rate Cut: Exuberance and Reality

THE recent rationalisation of GST rates seems to be a sigh of relief to consumers as well as to producers after facing a tyranny of cumbersome tax regime for eight long years since the introduction of GST in 2017.

From Migrants to Guests: The Kerala Experience

IN Kerala, there are no ‘migrant workers’ in the conventional sense; they are instead known as ’guest workers’. This framing itself reflects how the state perceives them. Nearly 35 lakh such workers are employed across Kerala, making the state their preferred destination. On the one hand, relatively high wages, steady demand for labour and safer working conditions attract them; on the other hand, unemployment, low wages and infrastructural deficits in their home states push them outward.

Decisive Verdict in BTC Polls: BJP–UPPL Rejected

THE recently concluded election to the Bodoland Territorial Council (BTC) has sent a clear and emphatic message: the people of the Bodoland Territorial Region (BTR) in Assam have rejected the communal, divisive, and opportunistic politics of the Bharatiya Janata Party (BJP) and its ally, the United People’s Party Liberal (UPPL).

AIKS Condemns Lynching of Cattle Trader by Cow Vigilante Gang

ALL India Kisan Sabha (AIKS) strongly protests against the inhuman and brutal lynching of Aasif Babu Multani alias Sheru Susadiya who died on September 20, 2025, at Sawai Man Singh Medical College, Jaipur. He was lynched by a gang of cow vigilante criminals in the early hours of September 16, when he was transporting cattle purchased from Lambia Raila cattle market near Bhilwara in Rajasthan to his village in Mandsaur in Madhya Pradesh.According to Superintendent of Police Bhilwara, Dharmendra Singh, five people have been arrested and an FIR registered.

Chandrachud and Bhagwat Are on the Same Page

FORMER Chief Justice of India DY Chandrachud’s recent interview with online portal Newslaundry turned out to contain some sensational and ominous revelations of his views. These have, naturally, created a stir seldom witnessed after former justices’ post-retirement thoughts. This is so because his statements not only reveal his real thinking but also add to a public discourse steadily being built up in recent times on one of the most incendiary and divisive issues that haunts India – religious conflict and its history, especially with regard to places of worship.

Big Tech’s Deep Links with the Genocide in Gaza

THE most recent revelations about Microsoft’s deep ties with Israel’s war machine have once again laid bare the central role of U.S. Big Tech in enabling the genocide in Gaza.

Trump Tariffs and GST Rate Adjustments

TRUMP’s tariff aggression against India will indubitably have a contractionary effect on the Indian economy. Even if Trump reduces tariffs from the 50 per cent he is currently levying, this will only be in exchange for India reducing its tariffs on American goods, especially agricultural goods and dairy products, which would mean larger imports from America and the hence reduced incomes in India.

Another Blow to Novartis and Its Patent Monopolies

THE Swiss multinational Novartis and the Indian Patent Office are in the news again, as is Section 3(d) of India's Patent Act. Under the 3(d) provision, the Patent Office struck down the Novartis patent on Vymada, a heart failure drug, for lacking either novelty or an inventive step. Vymada, internationally marketed as Entresto, is a combination of two drugs: sacubitril and valsartan, and Novartis was claiming that by mixing the two, it created a "supramolecular complex", a claim rejected by the Indian Patent Office.

Search form

Peoples Democracy newsletter